These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29112767)

  • 1. Fast and reliable diagnosis of XDR Acinetobacter baumannii meningitis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Brunetti G; Ceccarelli G; Giordano A; Navazio AS; Vittozzi P; Venditti M; Raponi G
    New Microbiol; 2018 Jan; 41(1):77-79. PubMed ID: 29112767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid antimicrobial susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry using a qualitative method in Acinetobacter baumannii complex.
    Li M; Liu M; Song Q; Xiong L; Chen Z; Kang M; Xie Y
    J Microbiol Methods; 2018 Oct; 153():60-65. PubMed ID: 30193924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia.
    Wenzler E; Goff DA; Mangino JE; Reed EE; Wehr A; Bauer KA
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):63-68. PubMed ID: 26603136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid bacterial identification in patients with smear-positive bacterial meningitis.
    Bishop B; Geffen Y; Plaut A; Kassis O; Bitterman R; Paul M; Neuberger A
    Clin Microbiol Infect; 2018 Feb; 24(2):171-174. PubMed ID: 28529026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of Matrix-Associated Laser Desorption/Ionization - Time of Flight Mass Spectrometry (MALDI-TOF MS) in discrimination at species level for Acinetobacter bacteremia.
    Wu MS; Collier S; Liu PY; Lee YT; Kuo SC; Yang YS; Chen TL; Shi ZY; Lin CF
    J Microbiol Methods; 2017 Sep; 140():58-60. PubMed ID: 28669800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumanii].
    Alaoui SY; Nejmi SE; Chakir AA; Hmamouchi B; Chlilek A
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):854-5. PubMed ID: 21981848
    [No Abstract]   [Full Text] [Related]  

  • 7. Acinetobacter baumannii meningitis in children: a case series and literature review.
    Xiao J; Zhang C; Ye S
    Infection; 2019 Aug; 47(4):643-649. PubMed ID: 30328074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of carbapenemases using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) meropenem hydrolysis assay.
    Hrabák J
    Methods Mol Biol; 2015; 1237():91-6. PubMed ID: 25319782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.
    Karaiskos I; Galani L; Baziaka F; Giamarellou H
    Int J Antimicrob Agents; 2013 Jun; 41(6):499-508. PubMed ID: 23507414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Jeong S; Hong JS; Kim JO; Kim KH; Lee W; Bae IK; Lee K; Jeong SH
    Ann Lab Med; 2016 Jul; 36(4):325-34. PubMed ID: 27139605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct application of MALDI-TOF mass spectrometry to cerebrospinal fluid for rapid pathogen identification in a patient with bacterial meningitis.
    Segawa S; Sawai S; Murata S; Nishimura M; Beppu M; Sogawa K; Watanabe M; Satoh M; Matsutani T; Kobayashi M; Iwadate Y; Kuwabara S; Saeki N; Nomura F
    Clin Chim Acta; 2014 Aug; 435():59-61. PubMed ID: 24797349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Mencacci A; Monari C; Leli C; Merlini L; De Carolis E; Vella A; Cacioni M; Buzi S; Nardelli E; Bistoni F; Sanguinetti M; Vecchiarelli A
    J Clin Microbiol; 2013 Feb; 51(2):603-6. PubMed ID: 23175257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI-TOF MS for identification of community-acquired Acinetobacter baumannii complex infections.
    McAuliffe GN; Baird RW; Hennessy J; Anstey NM; Davis JS
    Pathology; 2016 Jan; 48(1):100-2. PubMed ID: 27020225
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH; Tang YF; Su LH; Chien CC; Liu JW
    Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrathecal use of colistin].
    Charra B; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 Feb; 25(2):215. PubMed ID: 16311006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.